InMed Pharmaceuticals Inc. (INM) Reports Q1 Loss of $2.17

InMed Pharmaceuticals Inc. (NASDAQ: INM) reported Q1 EPS of ($2.17). Revenue for the quarter came in at $1.26 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• General Atlantic weighs return to IPO plans after 2023 filing, WSJ reports
• Target (TGT) PT Raised to $170 at DA Davidson Ahead of Q2 Earnings